HIV pre-exposure prophylaxis (PrEP) – Swedish recommendation for management 2026

Q: What does this research mean for the field?

Emtricitabine/tenofovir disoproxil fumarate (TDF) is recommended as pre-exposure prophylaxis (PrEP) for adults and adolescents at high risk of HIV infection in Sweden. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Jaran Eriksen; Emmi Andersson; Finn Filén; Åsa Haggren; Catharina Missailidis; Fredrik Månsson; Susanne Strömdahl; Petra Tunbäck

doi:10.1080/23744235.2026.2713548

August 25, 2026Scandinavian Journal of Infectious Diseases

HIV pre-exposure prophylaxis (PrEP) – Swedish recommendation for management 2026

View at Publisher

Ask AI

Bookmark

Share

Key Points

To provide updated clinical recommendations on the prescription, administration, and monitoring of emtricitabine/tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis.
Reviewed international clinical guidelines and evidence regarding pre-exposure prophylaxis efficacy and safety.
Synthesized management protocols for prescribing emtricitabine/tenofovir disoproxil fumarate to adults and adolescents at high risk of HIV infection.
Emtricitabine/tenofovir disoproxil fumarate is established as an effective preventive therapy to reduce HIV transmission when taken consistently.
Management guidelines emphasize regular renal function monitoring, periodic HIV and sexually transmitted infection screening, and adherence counseling.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Clinical guideline outlines management protocols for emtricitabine and tenofovir disoproxil fumarate pre-exposure prophylaxis in high-risk individuals, highlighting optimal prevention strategies.

Abstract

Emtricitabine/tenofovir disoproxil fumarate (TDF) is approved in Sweden for use as pre-exposure prophylaxis (PrEP) in adults and adolescents at high risk of HIV infection. International guidelines ...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Eriksen et al. (2026) studied this question.

synapsesocial.com/papers/6a8fea3310c91c1e92622458 https://doi.org/10.1080/23744235.2026.2713548

View at Publisher

Ask AI

Bookmark

Share

HIV pre-exposure prophylaxis (PrEP) – Swedish recommendation for management 2026

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

HIV pre-exposure prophylaxis (PrEP) – Swedish recommendation for management 2026

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading